DealBook: Illumina Buys Maker of Down Syndrome Test

Amid a report that Roche was no longer interested in a takeover, Illumina made a deal of its own in a sign that DNA sequencing is now moving toward being used for medical diagnosis.

Source: NYT Health - January 7, 2013 Category: Consumer Health News Authors: By ANDREW POLLACK Tags: Genetics and Heredity Verinata Health Inc DNA (Deoxyribonucleic Acid) Illumina Inc ILMN NASDAQ Roche Holding A G RHHBY Other OTC Down Syndrome Healthcare Mergers & Acquisitions Mergers, Acquisitions and Divestitures Tests (Medical) Source Type: news